Business
NuGen Medical Devices Inc. Provides Update on Health Canada License
Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse of its license with Health Canada. The Company's Health Canada Licence became expired due to an untimely certificate renewal. This is not a suspension or cancellation related to regulatory compliance or enforcement action. The temporary status does not constitute a product safety risk. However, to...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse of its license with Health Canada.","length":250,"tagName":"p"},{"type":"text","content":"The Company's Health Canada Licence became expired due to an untimely certificate renewal. This is not a suspension or cancellation related to regulatory compliance or enforcement action. The temporary status does not constitute a product safety risk. However, to remain compliant with Health Canada medical device regulations, NuGen is currently not selling the affected devices in Canada.","length":394,"tagName":"p"},{"type":"text","content":"A new licence application has already been submitted, and NuGen has been in active communication with Health Canada throughout the process. NuGen is confident the licence will be renewed soon, and sales will resume once the new licence becomes available. The Company's operations elsewhere in the world remain unaffected. The Company will continue to provide updates when available.","length":386,"tagName":"p"},{"type":"text","content":"About NuGen Medical Devices","length":27,"tagName":"p"},{"type":"text","content":"NuGen develops next-generation needle-free devices for subcutaneous drug delivery. Its flagship InsuJet™ system is approved in 42 countries and is designed to improve the lives of millions of people with diabetes worldwide.","length":223,"tagName":"p"},{"type":"text","content":"Websites: insujet.com | insujet.fr | nugenmd.com","length":48,"tagName":"p"},{"type":"text","content":"LinkedIn: https://www.linkedin.com/company/nugen-medical-devices","length":64,"tagName":"p"},{"type":"text","content":"Investor Relations: [email protected]","length":34,"tagName":"p"},{"type":"text","content":"For further information, please contact:Liang Lin, Chief Executive Officer+ [email protected]","length":107,"tagName":"p"},{"type":"text","content":"Notice Regarding Forward-Looking Information:","length":45,"tagName":"p"},{"type":"text","content":"Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release.","length":171,"tagName":"p"},{"type":"text","content":"This news rel...